New depression pill shows promise in early trial
NCT ID NCT03586427
First seen Apr 11, 2026 · Last updated May 15, 2026 · Updated 5 times
Summary
This study tested a new oral drug called zelquistinel in 251 adults with major depression. The goal was to see if a single dose could reduce depression symptoms within one day compared to a placebo. Results focus on changes in a standard depression rating scale.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSIVE DISORDER, MAJOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atlanta Center for Medical Research
Atlanta, Georgia, 30331, United States
-
Boston Clinical Trials
Boston, Massachusetts, 02131, United States
-
Center for Emotional Fitness
Cherry Hill, New Jersey, 08002, United States
-
Clinical Neuroscience Solutions, Inc - Memphis, TN
Memphis, Tennessee, 38119, United States
-
Collaborative Neuroscience Network
Torrance, California, 90502, United States
-
Donald J. Garcia, Jr., MD, PA
Austin, Texas, 78737, United States
-
Eastside Comprehensive Medical Center
New York, New York, 10128, United States
-
Elite Clinical Trials, Inc.
Wildomar, California, 92595, United States
-
Finger Lakes Clinical Research
Rochester, New York, 14618, United States
-
FutureSearch Trials of Dallas, LP
Dallas, Texas, 75231, United States
-
Hassman Research Institute
Berlin, New Jersey, 08009, United States
-
Health Initiatives Research PLLC
Fayetteville, Arkansas, 72703, United States
-
IPS Research
Oklahoma City, Oklahoma, 73106, United States
-
Neuro-Behavioral Clinical Research, Inc
North Canton, Ohio, 44720, United States
-
Neurobehavioral Research, Inc
Cedarhurst, New York, 11516, United States
-
North County Clinical Research, Inc.
Oceanside, California, 92054, United States
-
Northwest Clinical Research Center
Bellevue, Washington, 98007, United States
-
Pacific Research Partners, LLC
Oakland, California, 94607, United States
-
Pillar Clinical Research
Lincolnwood, Illinois, 60712, United States
-
Research Strategies of Memphis, LLC
Memphis, Tennessee, 38119, United States
-
Synexus US - Atlanta
Atlanta, Georgia, 30328, United States
-
Synexus US - Cerritos
Cerritos, California, 90703, United States
-
Synexus US - Queens
Jamaica, New York, 11432, United States
-
Wake Research - Pharmacology Research Institute
Encino, California, 91316, United States
-
Wake Research - Pharmacology Research Institute
Newport Beach, California, 92660, United States
Conditions
Explore the condition pages connected to this study.